Insomnia Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION

Insomnia is a condition in which a person faces difficulty while falling asleep, waking up during sleep and as well as feeling tired on waking. Insomnia is linked with other health problems like asthma, depression, arthritis or pain. The causes of insomnia can be included such as depression, stress, illness and emotional or physical discomfort.

MARKET DYNAMICS

The insomnia market is anticipated to grow in the forecast period owing to increasing prevalence of insomnia and growing demand for its innovative treatment, emergence of therapeutics with fewer side effects as well as stressful work and working in shifts. Moreover, rise in demand for OTC sleep aids is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Insomnia Market Analysis to 2031" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of insomnia market with detailed market segmentation by drug class, distribution channel and geography. The global insomnia market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading insomnia market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global insomnia market is segmented on the basis of drug class and distribution channel. Based on drug class, the market is classified as antidepressants, melatonin antagonist, benzodiazepines, nonbenzodiazepines, orexin and antagonist. On the basis of distribution channel the insomnia market is divided as Hospital Pharmacies, Retail Pharmacies, Drug Stores and Online Pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global insomnia market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The insomnia market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting insomnia market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the insomnia market in these regions.

MARKET PLAYERS

The reports cover key developments in the insomnia market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from insomnia market are anticipated to lucrative growth opportunities in the future with the rising demand for insomnia market in the global market. Below mentioned is the list of few companies engaged in the insomnia market.
The report also includes the profiles of key insomnia market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Mallinckrodt
• Eisai Co., Ltd.
• Merck Sharp & Dohme Corp. (Merck & Co., Inc)
• Galt Pharmaceuticals, LLC.
• Pfizer Inc.
• Sanofi
• Sumitomo Dainippon Pharma Co., Ltd.
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceutical Industries Ltd.
• Vanda Pharmaceuticals

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Insomnia Report Scope